vs
Side-by-side financial comparison of Global Indemnity Group, LLC (GBLI) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
Global Indemnity Group, LLC is the larger business by last-quarter revenue ($116.7M vs $75.5M, roughly 1.5× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 7.6%). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 2.0%).
Global Indemnity Group LLC is a specialty insurance holding company that provides tailored commercial and personal property and casualty insurance products, as well as surety and reinsurance solutions. It primarily serves small to mid-sized enterprises and niche personal line segments across the United States, focusing on underserved specialty risk categories through its licensed subsidiary insurance carriers.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
GBLI vs PBYI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $116.7M | $75.5M |
| Net Profit | $6.5M | — |
| Gross Margin | — | 69.3% |
| Operating Margin | 7.9% | 22.7% |
| Net Margin | 5.5% | — |
| Revenue YoY | 7.6% | 27.7% |
| Net Profit YoY | -28.5% | — |
| EPS (diluted) | $0.48 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $116.7M | $75.5M | ||
| Q3 25 | $114.2M | $54.5M | ||
| Q2 25 | $110.5M | $52.4M | ||
| Q1 25 | $108.7M | $46.0M | ||
| Q4 24 | $108.4M | $59.1M | ||
| Q3 24 | $111.8M | $80.5M | ||
| Q2 24 | $108.7M | $47.1M | ||
| Q1 24 | $112.3M | $43.8M |
| Q4 25 | $6.5M | — | ||
| Q3 25 | $12.5M | $8.8M | ||
| Q2 25 | $10.3M | $5.9M | ||
| Q1 25 | $-4.0M | $3.0M | ||
| Q4 24 | $9.0M | — | ||
| Q3 24 | $12.8M | $20.3M | ||
| Q2 24 | $10.1M | $-4.5M | ||
| Q1 24 | $11.4M | $-4.8M |
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
| Q4 25 | 7.9% | 22.7% | ||
| Q3 25 | 14.1% | 17.6% | ||
| Q2 25 | 11.9% | 12.7% | ||
| Q1 25 | -4.7% | 8.7% | ||
| Q4 24 | 11.2% | 22.6% | ||
| Q3 24 | 14.2% | 27.4% | ||
| Q2 24 | 11.7% | -4.6% | ||
| Q1 24 | 12.7% | -5.3% |
| Q4 25 | 5.5% | — | ||
| Q3 25 | 11.0% | 16.2% | ||
| Q2 25 | 9.4% | 11.2% | ||
| Q1 25 | -3.7% | 6.5% | ||
| Q4 24 | 8.3% | — | ||
| Q3 24 | 11.4% | 25.2% | ||
| Q2 24 | 9.3% | -9.6% | ||
| Q1 24 | 10.1% | -11.0% |
| Q4 25 | $0.48 | $0.26 | ||
| Q3 25 | $0.86 | $0.17 | ||
| Q2 25 | $0.71 | $0.12 | ||
| Q1 25 | $-0.30 | $0.06 | ||
| Q4 24 | $0.65 | $0.40 | ||
| Q3 24 | $0.92 | $0.41 | ||
| Q2 24 | $0.73 | $-0.09 | ||
| Q1 24 | $0.82 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $65.5M | $97.5M |
| Total DebtLower is stronger | — | $22.7M |
| Stockholders' EquityBook value | $706.6M | $130.3M |
| Total Assets | $1.7B | $216.3M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $65.5M | $97.5M | ||
| Q3 25 | $75.4M | $94.4M | ||
| Q2 25 | $67.3M | $96.0M | ||
| Q1 25 | $81.1M | $93.2M | ||
| Q4 24 | $17.0M | $101.0M | ||
| Q3 24 | $31.0M | $96.7M | ||
| Q2 24 | $46.7M | $96.8M | ||
| Q1 24 | $38.9M | $107.2M |
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
| Q4 25 | $706.6M | $130.3M | ||
| Q3 25 | $704.1M | $115.3M | ||
| Q2 25 | $695.3M | $104.7M | ||
| Q1 25 | $687.1M | $97.1M | ||
| Q4 24 | $689.1M | $92.1M | ||
| Q3 24 | $686.7M | $71.1M | ||
| Q2 24 | $667.5M | $48.5M | ||
| Q1 24 | $659.5M | $51.0M |
| Q4 25 | $1.7B | $216.3M | ||
| Q3 25 | $1.7B | $202.9M | ||
| Q2 25 | $1.7B | $194.9M | ||
| Q1 25 | $1.7B | $196.2M | ||
| Q4 24 | $1.7B | $213.3M | ||
| Q3 24 | $1.8B | $220.7M | ||
| Q2 24 | $1.7B | $205.0M | ||
| Q1 24 | $1.7B | $214.1M |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $9.1M | $14.4M |
| Free Cash FlowOCF − Capex | — | $14.4M |
| FCF MarginFCF / Revenue | — | 19.1% |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | 1.40× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $9.1M | $14.4M | ||
| Q3 25 | $5.7M | $9.7M | ||
| Q2 25 | $7.0M | $14.1M | ||
| Q1 25 | $2.4M | $3.6M | ||
| Q4 24 | $38.8M | $15.6M | ||
| Q3 24 | $15.3M | $11.0M | ||
| Q2 24 | $14.3M | $1.0M | ||
| Q1 24 | $22.7M | $11.2M |
| Q4 25 | — | $14.4M | ||
| Q3 25 | — | $9.7M | ||
| Q2 25 | — | $14.1M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | — | $11.0M | ||
| Q2 24 | — | $1.0M | ||
| Q1 24 | — | — |
| Q4 25 | — | 19.1% | ||
| Q3 25 | — | 17.7% | ||
| Q2 25 | — | 26.8% | ||
| Q1 25 | — | 7.7% | ||
| Q4 24 | — | 26.4% | ||
| Q3 24 | — | 13.7% | ||
| Q2 24 | — | 2.1% | ||
| Q1 24 | — | — |
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 0.0% |
| Q4 25 | 1.40× | — | ||
| Q3 25 | 0.45× | 1.10× | ||
| Q2 25 | 0.68× | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | 4.30× | — | ||
| Q3 24 | 1.20× | 0.54× | ||
| Q2 24 | 1.41× | — | ||
| Q1 24 | 2.00× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GBLI
| Belmont Core | $99.2M | 85% |
| Agency And Insurance Services | $13.8M | 12% |
| Other | $3.7M | 3% |
PBYI
Segment breakdown not available.
